BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 4309326)

  • 1. [Vaccination against poliomyelitis. Formation of immunity evaluated according to the results of serological surveys].
    Zabicka J
    Przegl Epidemiol; 1981; 35(3):385-9. PubMed ID: 6276928
    [No Abstract]   [Full Text] [Related]  

  • 2. Benefits and risks of attenuated polio vaccine strains in a community immunized with inactivated polio vaccine.
    Rossier E; Phipps PH; Pépin O
    Dev Biol Stand; 1979; 43():179-85. PubMed ID: 520669
    [No Abstract]   [Full Text] [Related]  

  • 3. Poliomyelitis vaccines in Belgium: 20 years of experience.
    Andre FE
    Dev Biol Stand; 1979; 43():187-93. PubMed ID: 230109
    [No Abstract]   [Full Text] [Related]  

  • 4. [Will Salk's polio vaccination be used again?].
    Stickl H
    Fortschr Med; 1978 Apr; 96(13):688-94. PubMed ID: 631710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Poliomyelitis vaccination in Denmark].
    Petersen I
    Ugeskr Laeger; 1985 Jan; 147(4):265-9. PubMed ID: 3976028
    [No Abstract]   [Full Text] [Related]  

  • 6. [Findings on the success of vaccination and revaccination with live and inactivated vaccines against poliomyelitis].
    Dostal V; Haenzel I; Sturm W
    Schweiz Med Wochenschr; 1969 Sep; 99(37):1322-4. PubMed ID: 4309326
    [No Abstract]   [Full Text] [Related]  

  • 7. [Worldwide eradication of poliomyelitis].
    Rasch G; Schreier E; Kiehl W; Kurth R
    Wien Klin Wochenschr; 2001 Oct; 113(20-21):839-45. PubMed ID: 11732120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [End phase challenges of poliomyelitis eradication programme realization].
    Jarzabek Z
    Przegl Epidemiol; 2005; 59(1):59-68. PubMed ID: 16013411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk management in a polio-free world.
    Bruce Aylward R; Sutter RW; Cochi SL; Thompson KM; Jafari H; Heymann D
    Risk Anal; 2006 Dec; 26(6):1441-8. PubMed ID: 17184391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Criteria for control of infectious diseases with poliomyelitis as an example.
    Evans AS
    Prog Med Virol; 1984; 29():141-65. PubMed ID: 6322231
    [No Abstract]   [Full Text] [Related]  

  • 11. [Poliomyelitis: vaccination is still important].
    Pregliasco F; Minolfi V; Binda S; Andreassi A; Profeta ML
    Ann Ig; 1994; 6(4-6):675-84. PubMed ID: 8611242
    [No Abstract]   [Full Text] [Related]  

  • 12. Eradication of polio by vaccination.
    Minor PD
    Virology; 2000 Mar; 268(2):231-2. PubMed ID: 10704330
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.